本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 70 million (USD 460,0001) for the development of a prototype detection test for mpox (formerly known as monkeypox2). Mpox is a viral infectious disease that has been spreading in the Democratic Republic of the Congo (DRC) and across sub-Saharan Africa. According to a situation report by the World Health Organization (WHO), more than 170,000 cases of mpox were confirmed in 141 countries between January 2022 and October 20253. WHO also reported that surveillance data for the January-May 2024 period in DRC indicated that 62% of the fatalities occurred in children aged under 5 years, where the case fatality ratio in this age group ranged from approximately 7 to 9%4. Due to the sharp increase in cases, a Public Health Emergency of International Concern (PHEIC) was declared again in August 2024 against the widespread outbreak in the African region, following the declaration made in July 2022. Although the emergency declaration was lifted in September 2025, mpox cases continue to be reported in neighboring countries, and the risk of severe complications and re-emergence remains a concern 5. Mpox is mainly classified into two strains/clades, and infection rates and disease severity vary depending on the type. Locally, diagnostic systems currently available for identifying the clades remain insufficient, and developing simple and rapid diagnostic tests with clade distinguishing capabilities is urgently needed to prevent the further spread of infection. Against this background, the GHIT Fund will invest approximately 70 million yen (USD 460,0001) in the development of a prototype mpox detection test. The project involves NIPRO CORPORATION, a global comprehensive healthcare company in the medical devices and pharmaceuticals; TBA Co., Ltd, a venture company originating from Tohoku University; the Japan Institute for Health Security (JIHS); the international non-profit organization PATH (USA); and the Institut National de Recherche Biomédicale (INRB). The project seeks to develop a prototype detection test capable of distinguishing clades using the Iso-PAS method—an inexpensive and simple genetic testing technique—and its performance will be evaluated. This will enable easy testing even in facilities with limited infrastructure, facilitating prompt and appropriate treatment while helping to prevent the spread of infection. The GHIT Fund joined the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) 6 as a member in September 2025. GloPID-R brings together funders investing in research related to new or re-emerging infectious diseases. The GHIT Fund is the second organization from Japan to join GloPID-R as a member after the Japan Agency for Medical Research and Development (AMED). We will continue to support the development of innovative diagnostic technologies to enable swift responses to future public health challenges. 1 USD1 = JPY154.10, the approximate exchange rate on October 31, 2025.2 Mpox was renamed from monkeypox by WHO in 2022https://www.who.int/news/item/28-11-2022-who-recommends-new-name-for-monkeypox-disease3 WHO: Global Mpox Trends. https://worldhealthorg.shinyapps.io/mpx_global/ (Published on November 21, 2025)4 WHO: Disease Outbreak News Mox – Democratic Republic of the Congo https://www.who.int/emergencies/disease-outbreak-news/item/2024-DON522 (Published on June 21, 2024)5 Africa CDC: https://africacdc.org/news-item/mpox-still-a-continental-emergency-africa-cdc-advisory-group-recommends/(Published on September 4)6 GloPID-R Secretariat receives funding from the European Union's Horizon Europe research and innovation program. The GHIT Fund is a Japan-based international public-private partnership (PPP) fund that was formed between the Government of Japan, multiple pharmaceutical companies, the Gates Foundation, Wellcome, and the United Nations Development Programme (UNDP). The GHIT Fund invests in and manages an R&D portfolio of development partnerships aimed at addressing neglected diseases, such as malaria, tuberculosis, and neglected tropical diseases, which afflict the world's vulnerable and underserved populations. In collaboration with global partners, the GHIT Fund mobilizes Japanese industry, academia, and research institutes to create new drugs, vaccines, and diagnostics for malaria, tuberculosis, and neglected tropical diseases.https://www.ghitfund.org/en Appendix: Project Details ID: G2025-125 Project Title Development and performance evaluation of Iso-PAS technology for mpox detection (Iso-PAS Mpox) Collaboration Partners 1. NIPRO CORPORATION (Japan) 2. TBA Co., Ltd. (Japan) 3. Japan Institute for Health Security (JIHS/ Japan) 4. PATH (USA) 5. Institut National de Recherche Biomédicale(INRB/ Democratic Republic of the Congo) Disease Mpox Intervention Diagnostic Stage Technical Feasibility Awarded Amount JPY 71,279,693 (USD 462,555) Status New Project Summary [Project objective] A test kit will be developed that can distinguish between MPXV Clade I and Clade II using the Iso-PAS method, an inexpensive and simple genetic testing method. A future aim is to register the test kit on the WHO Emergency Use Listing (EUL) following the accumulation of proven data from MPXV outbreak regions. [Project design] The following activities are to be implemented in the project: 1) Development of a prototype Iso-PAS Mpox test kit, and its performance evaluation. 2) Performance study of the prototype kit using clinical specimens from the DRC. Project Detail https://www.ghitfund.org/investment/portfoliodetail/detail/250/en *All amounts are listed at an exchange rate of USD1 = JPY154.10, the approximate exchange rate on October 31, 2025. To learn more about the GHIT Fund's investments, please visit Investment Overview: https://www.ghitfund.org/investment/overview/enPortfolio: https://www.ghitfund.org/investment/portfolio/enAdvancing Portfolio: https://www.ghitfund.org/investment/advancingportfolio/enClinical Candidates: https://www.ghitfund.org/investment/clinicalcandidates/en For more information, contact:Nancy Moss at +1-908-606-8940 or nmoss@burness.comMina Ohata at +81-36441-2032 or mina.ohata@ghitfund.org
NICOSIA, Cyprus, Nov. 24, 2025 /PRNewswire/ -- ISX Financial EU Plc ("ISXX") announces that it has received AU$5,556,608.72 in cleared electronic funds relating to its 27.595% shareholding in NSX Ltd. Settlement of the equity consideration was completed late last week. In addition to the equity consideration above, ISXX has received the agreed interest to date, restructuring and establishment fees totalling AU$3,014,438.14, associated with the loan restructuring of two convertible notes extended to the NSX Ltd. The equity sale was via a scheme of arrangement for 100% takeover of the NSX Ltd by CNSX Global Markets Inc. ("CNSX Group"), the parent of the Canadian Securities Exchange ("CSE"). The scheme offer was an all-cash consideration of AU$0.04 per fully paid ordinary share. The closing of the equity sale, pursuant to a scheme of arrangement, follows the satisfaction of all necessary conditions, including approval of NSX shareholders, finalisation of funding and the receipt of ASIC and court approvals. NSX shareholders overwhelmingly supported the transaction with 94.78% of votes in favour. ISXX no longer holds any equity interest in the NSX Ltd. In addition to the equity sale, ISXX's previous convertible loan agreements extended to the NSX have now been replaced with two new senior term loan facilities, each extended by one additional year beyond their original maturity dates. Under the revised structure, all conversion features have been removed, and the loans now carry a fixed 18% annual interest rate. ISXX now expects both facilities to continue performing until their extended maturities in August 2027 and January 2028, unless NSX elects to repay earlier under the new contractual provisions. Should the NSX choose early repayment, ISXX benefits from a make-whole clause, which ensures ISXX receives the full discounted economic value of interest through to the original end-dates, protecting the return profile. Based on the revised terms, and assuming no early repayment, ISXX expects to further receive cAU$5.14 million in total principal and interest over the life of the two new facilities. Mr. Nikogiannis Karantzis, CEO of ISX Financial EU Plc, said: "On behalf of ISXX, we wish the NSX and its new owners, the CNSX, all the best in their new Australian endeavour. The divestment of NSX allows ISXX to focus on its core operations and growth in the Northern Hemisphere. The divestment and loan restructuring is expected to contribute a total of cAU$13.8m back to ISXX's balance sheet when finalised, providing supplementary regulatory capital for expansion into new markets and services for new licenses, in addition to funding for prospective acquisitions." The National Stock Exchange of Australia is a wholly owned subsidiary of the NSX Ltd, and is a Tier 1 market operator licensee regulated by the Australian Securities and Investments Commission (ASIC). ISXX has been a beneficial owner of the ASIC regulated National Stock Exchange of Australia through its parent NSX Ltd since early 2020. Mr. Karantzis was CEO of the NSX Ltd from March 2020 until March 2022. NSX Ltd and ISXX's subsidiary, Clearpay, launched a blockchain-based securities clearing system in 2021 in compliance with ASIC requirements. This system, called the Digital Exchange Subregister System (DESS) is operated by ClearPay, and is designed to modernise clearing and settlement by creating a new Delivery versus Payment (DvP) platform to eventually supersede conventional clearing and settlement systems. DESS has upcoming applications in the mint and burn of stablecoins, which ISXX will explore in connection with its fiat processing systems. ISXX continues to provide IT services to the NSX in support of DESS. About ISX Financial EU PlcHeadquartered in Nicosia, ISX Financial EU Plc (ISXX, LEI: 213800NGHVYL5PFZI692) is a leading banktech company EEA authorised as an Electronic Money Institution by the Central Bank of Cyprus and regulated in the UK by the Financial Conduct Authority. For all the latest company announcements and media - visit our Investor Relations page: https://www.isx.financial/investors
Grant Proceeds Will Accelerate Research and Commercialization of Electrochemical Manufacturing of High-Performance Graphite DALLAS, Nov. 21, 2025 /PRNewswire/ -- Solidion Technology Inc. ("Solidion" or the "Company") (Nasdaq: STI), an advanced battery technology solutions provider, was notified by the U.S. Department of Energy (DOE) that it has been awarded a grant to advance research and development of Electrochemical Manufacturing of High-Performance Graphite Based on Biomass-Derived Carbon. This award is one of the projects funded by ARPA-E, the Advanced Research Projects Agency, from their highly competitive OPEN program. The Company previously announced that it had received the prestigious 2025 R&D 100 Award in partnership with Oak Ridge National Laboratory (ORNL), for innovation in Electrochemical Graphitization in Molten Salts (E-GRIMS). KEY HIGHLIGHTS OF DEPARTMENT OF ENERGY GRANT Collaboration: Research to be conducted jointly with Oak Ridge National Laboratory Independence: Assists in the Department of Energy's mission to reduce imports of critical energy materials from foreign sources, improve American energy independence, and ensure that the U.S. maintains a technological lead in developing and deploying advanced energy technologies. Jaymes Winters, Chief Executive Officer of Solidion Technology, stated: "This award demonstrates the cutting edge superiority of Solidion's extensive patent portfolio and innovation. As a U.S. manufacturer, Solidion is poised to take advantage of its vast technological abilities" About Solidion Technology, Inc. Headquartered in Dallas, Texas with pilot production facilities in Dayton, Ohio, Solidion's (NASDAQ: STI) core business includes manufacturing of battery materials and components, as well as development and production of next-generation batteries for energy storage systems, including UPS systems serving the artificial intelligence (AI) data center market and electric vehicles for ground, aerospace, and sea transportation. Solidion holds a portfolio of over 525 patents, covering innovations such as high-capacity, silane gas free and graphene-enabled silicon anodes, biomass-based graphite, advanced lithium-sulfur and lithium-metal technologies. For more information, please visit www.solidiontech.com or contact Investor Relations. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Solidion Technology Inc., (NASDAQ: STI) (the "Company," "Solidion," "we," "our" or "us") desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words "forecasts" "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required by law.
TOKYO, Nov. 19, 2025 /PRNewswire/ -- note inc. ("note") announced that it has entered into a capital and business alliance with NAVER Corporation, South Korea's leading internet company, receiving an investment of 2 billion yen. Through this partnership, the two companies aim to collaboratively build a new global ecosystem for creation and distribution in the age of generative AI -- enabling creators to connect with fans worldwide and sustain their creative activities. Image: https://cdn.kyodonewsprwire.jp/prwfile/release/M108467/202511149150/_prw_PI1fl_R65C9zWP.png Overview of the Alliance1. Collaboration in Generative AI Technologiesnote and NAVER will jointly advance the use of AI and emerging technologies in creative fields. By combining their AI capabilities, the companies will develop and enhance services that improve the discovery, production, and distribution of digital content and support creators' work. 2. Integration Between PlatformsThe two companies will explore opportunities for cross-distribution of content and IP across their respective platforms, as well as initiatives for global expansion. They will also work to create mechanisms that strengthen relationships between creators and fans and expand the user-generated content (UGC) ecosystem. 3. Co-development and Global Expansion of IPNAVER operates a robust content ecosystem driven by its global digital comics platform WEBTOON, which distributes a wide range of vertical-scrolling webcomics to audiences in more than 150 countries. Works originating as webcomics often expand into animation, film, and live-action adaptations.note and its subsidiary Tales & Co. will combine their creator-support networks with NAVER Group assets -- including LINE Manga -- to discover and nurture new creators and works. The first joint project is scheduled to begin in early 2026. 4. Strategic Investment InitiativesTo accelerate these efforts, the two companies will jointly explore strategic investment opportunities. Leveraging their respective expertise and networks, they aim to expand business domains and strengthen global competitiveness. Background: https://kyodonewsprwire.jp/attach/202511149150-O1-c283iIn8.pdf Comments from Executives: https://kyodonewsprwire.jp/attach/202511149150-O2-28i910Jq.pdf About NAVER Corporation: https://kyodonewsprwire.jp/attach/202511149150-O3-Ul4q663S.pdf About note: https://kyodonewsprwire.jp/attach/202511149150-O4-5hF3XC6M.pdf URL: https://note.com/ Corporate website: https://ir.note.jp/en
SINGAPORE, Nov. 18, 2025 /PRNewswire/ -- Blue Planet Environmental Solutions, a Singapore-headquartered sustainability company pioneering technology-driven, IP-based waste management and upcycling solutions, today announced a strategic investment from Novo Holdings, a leading global investor focused on advancing planetary health, sustainability, and environmental stewardship. A panoramic look at Blue Planet’s circular waste infrastructure advancing Zero Waste to Landfill. Founded in 2017, Blue Planet has developed an integrated platform for circular waste management that combines proprietary technologies, data analytics, and operational expertise to convert waste into valuable resources. Its group portfolio includes Zigma (India), Wah & Hua (Singapore), Smart Environmental (New Zealand) and few others delivering end-to-end solutions across landfill remediation, recycling, biofuel generation, and e-waste processing. The investment from Novo Holdings strengthens Blue Planet's technology-driven model and supports its commitment in building a circular, low-carbon economy in high-growth markets. The partnership will enable the company to expand sustainable infrastructure across India, Southeast Asia, New Zealand, and Gulf Cooperation Council (GCC) markets, deepen operational synergies across its regional network, and continue strategic, M&A-driven growth in identified segments. It will also reinforce initiatives in carbon credit generation, circular resource management, ESG-linked innovation, and development of environmentally friendly products from landfill waste. Madhujeet Chimni, Founder and Chairman, Blue Planet Environmental Solutions, said: "We are excited to partner with Novo Holdings, whose global sustainability expertise aligns with our vision of building scalable, responsible waste solutions. This investment strengthens our strategic expansion into Southeast Asia and GCC markets, and enables continued M&A-driven growth in priority segments. It positions Blue Planet to deliver measurable social and economic impact while advancing Zero Waste to Landfill across the regions we serve." Prashant Singh, Co-Founder and CEO, Blue Planet Environmental Solutions, said: "This partnership empowers us to continue our strong focus on innovation across our platform and deploy advanced waste valorisation technologies, including converting landfill materials into high-value products such as pellets and cladding. It also supports our mission to expand sustainable infrastructure and develop data-driven circular models that reduce environmental footprints, drive resource efficiency, and create long-term value for industries and cities." Deepa Hingorani, Partner and Head of Asia, Planetary Health Investments, Novo Holdings, commented: "The rapid pace of urbanisation across Asia is intensifying the need for sustainable and context-specific waste solutions. Blue Planet exemplifies the type of knowledge-driven, impact-oriented platform that promotes resource efficiency and circularity. We are impressed by the company's vision and execution and look forward to supporting its continued growth." About Blue Planet Environmental Solutions Founded in 2017, Blue Planet Environmental Solutions is a Singapore-headquartered company pioneering regional sustainability through technology-driven and IP-based, end-to-end waste management and upcycling solutions. Operating across Southeast Asia, India, the UK, and New Zealand, Blue Planet's activities include landfill reclamation, hazardous and e-waste recycling, biogas production, and energy recovery. Blue Planet's mission is to create scalable circular ecosystems that extract higher value from waste, reduce environmental footprints, and enable a resource-efficient economy, advancing its vision of Zero Waste to Landfill.www.blueplanet.asia About Novo Holdings Novo Holdings is a holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation. Its purpose is to improve people's health and the sustainability of society and the planet by generating attractive long-term returns on the Foundation's assets. Wholly owned by the Foundation, Novo Holdings is the controlling shareholder of Novo Nordisk A/S and Novonesis A/S (formerly Novozymes A/S) and manages an investment portfolio with a long-term return perspective. In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure, and private equity assets, Novo Holdings is a world-leading life sciences investor. Through its Seed, Venture, Growth, Asia, Planetary Health, and Principal Investments teams, Novo Holdings invests in life sciences companies at all stages of development. As of year-end 2024, Novo Holdings had total assets of EUR 142 billion.www.novoholdings.dk
SHANGHAI, Nov. 12, 2025 /PRNewswire/ -- The leading electric vertical take-off and landing (eVTOL) firm, TCab Tech, has announced the completion of its RMB 300 million (approx. USD 43 million) Series B++ funding round, jointly invested by Meridian Capital, HuaHan Capital, and Puhua Capital. This is TCab Tech's second funding round completed in 2025 and the seventh since its founding, bringing the company's total funding to over RMB 1 billion (approx. USD 143 million). This funding marks the first major investment in China's low-altitude economy sector since the industry was designated as a strategic emerging sector under the China's 15th Five-Year Plan (2026-2030). It reflects both policy endorsement and market confidence in TCab Tech's technological path, engineering maturity, and commercialization potential. With the dual momentum of policy and capital, TCab Tech is accelerating the airworthiness certification efforts and commercial deployment of its flagship E20 eVTOL, moving into a new phase of scalable industrialization. Global Benchmarking and Deep R&D: Building a Competitive Edge in eVTOL Technology 1. Precisely Defined Technology Path — Tilt-rotor configuration Crosses the Commercial Threshold Since its founding, TCab Tech has focused on the tilt-rotor configuration, widely recognized as the optimal path for Advanced Air Mobility (AAM). The self-developed E20 achieves a cruise speed of 320 km/h, range of 200 km, and payload of 450 kg, combining vertical take-off and landing capability with efficient forward flight—laying the foundation for true commercial viability. 2. Engineering Maturity — CEO Onboard Flight Test Validates System Reliability The E20 has completed over 1,000 flight tests, including the world's first multi-passenger eVTOL flight with the CEO onboard, demonstrating exceptional system stability and reliability. The aircraft has now entered the compliance verification stage of airworthiness certification, targeting certification in 2027. 3. International Market Breakthrough — Record-Breaking Overseas Order In July 2025, TCab Tech signed an MoU with Autocraft, an Abu Dhabi technology enterprise of the UAE, outlining the potential delivery of up to 350 electric aircraft in the coming years. This represents the largest overseas order ever signed by a Chinese eVTOL company, underscoring strong global recognition of TCab Tech's technology and product competitiveness. Strategic Investment: Multi-Dimensional Empowerment for Commercialization Acceleration The joint investment from three leading institutions provides TCab Tech with far more than financial support — it brings global resources, industrial collaboration, and strategic post-investment management to accelerate the E20 eVTOL's commercialization journey. Weiwei Wang, Managing Partner at Meridian Capital, stated: "The low-altitude economy carries both strategic and economic significance for China and is one of Meridian Capital's core focus areas. Although the industry is still at an early stage, its development path has become increasingly clear. We prioritize investment in key value-chain enterprises with strong R&D and airworthiness capabilities. TCab Tech excels in both, currently standing among the first-tier players in the certification process. Yon (TCab Tech's Founder & CEO) personal participation in manned test flights further reinforces our confidence in product safety. In addition, the team's strong professional background and international outlook — featuring talent from Airbus and the new energy vehicle sector — make TCab Tech exceptionally competitive. We believe the company is well positioned to emerge as a global leader in the eVTOL industry." Meng Wang, Partner at HuaHan Capital, stated: "We have long believed in and systematically invested in the low-altitude economy. The tilt-rotor configuration has become the globally converging technological direction, and TCab Tech is among the first in China to achieve manned flight and stability verification on this path. More importantly, the company has built a comprehensive engineering system that ensures stable, long-duration, and safe flight. Its ability to combine frontier R&D with scalable industrial execution is a core advantage — and the reason we are committed to long-term partnership." Xiaofeng Wu and Jingwen Ni, Partners at Puhua Capital, stated: "Puhua Capital continues to focus its investments on the low-altitude economy. TCab Tech demonstrates exceptional industrial coordination and manufacturing maturity. By establishing deep co-development programs with top-tier aerospace suppliers, the company ensures aviation-grade reliability across critical systems. This forward-looking supply chain strategy provides high certainty for E20's airworthiness certification and enables a smooth transition to commercial operations — building a solid and sustainable competitive advantage. We look forward to TCab Tech accelerating certification and deployment, redefining the future of urban air mobility." Industrial Collaboration: Joint Development to Ensure Certification Certainty TCab Tech has established a supply chain ecosystem that meets international aviation certification standards, collaborating with leading global suppliers to ensure the E20 eVTOL meets stringent airworthiness requirements. International Collaboration: Partnering with Safran, a Fortune Global 500 company, to integrate its world's first EASA-certified electric motor for Air Mobility (for eVTOL)—ensuring propulsion safety and reliability Domestic Collaboration: Partnering with AVIC Xi'an Aeronautics Computing Technique Research Institute (for avionics and flight control), Farasis Energy (for batteries), and Hengshen Co. (for composite materials), among other top Chinese suppliers, to achieve aviation-grade reliability across all critical systems. This systematic and deeply collaborative approach has built a robust industrial foundation, ensuring certainty in E20's certification process and readiness for large-scale global production. Yon Wui NG, Founder and CEO of TCab Tech, stated: "China possesses globally leading advantages in policy support, industrial infrastructure, supply chain capabilities, and engineering manufacturing. These strengths position China to become a core driving force in global eVTOL technological innovation and commercialization. This round of funding will accelerate the airworthiness certification and mass-production readiness of the E20 eVTOL." Contact: media@tcabtech.com Website: www.tcabtech.com/en/
A12 藝術空間
Financing agreements
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
